Valuing Celegene’s CVR
Anyone ever look at the HBS case study? Should Tanaka buy more CVRs, hold, or sell her CVRs? Thanks!
Trending Content - Investment Banking Forum
| +131 | New Article: Dramatic Slide as UBS #22 (US) & New Leadership Desperately Needed | 25 | 19h |
| +121 | Americas M&A League Table Q2 Updated | 55 | 2h |
| +76 | Wealthy Parents / Jaded | 24 | 1d |
| +61 | A COMPLETE GUIDE TO SUMMER INTERNSHIP RECRUITING | 11 | 1d |
| +59 | How are hours rn for SA (interns) | 31 | 1d |
| +44 | Boutique firm wants access to my LinkedIn? | 38 | 5h |
| +33 | Investment Banking in Mexico | 9 | 1d |
| +30 | Investment Banking is Hard | 13 | 7h |
| +27 | Restructuring: Anti-climactic Experience | 3 | 9h |
| +21 | Excel macros for QOL formatting | 0 | 4d |
Career Resources
